1
One Year Post Exclusivity Adverse
Event Review Update:
Orlistat
Pediatric Advisory Committee Meeting
April 11, 2007
Hari Cheryl Sachs, MD, FAAP
Medical Officer
Pediatric and Maternal Health Staff
Office of New Drugs
Food and Drug Administration